45 results
8-K
AUTL
Autolus Therapeutics plc
1 Apr 24
Departure of Directors or Certain Officers
7:06am
biopharmaceutical company (now a wholly-owned subsidiary of Merck & Co., Inc.), from 2003 until his retirement in 2014. From 2002 to 2003, he served
S-3ASR
AUTL
Autolus Therapeutics plc
28 Mar 24
Automatic shelf registration
4:10pm
. federal income tax purposes (and investors therein);
regulated investment companies or real estate investment trusts;
tax qualified retirement plans
10-K
2023 FY
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
or our subsidiaries into money purchase plans for the year ended December 31, 2023 to provide pension, retirement or similar benefits to, our directors … or not a director, in all capacities was $11.4 million. The amount set aside or accrued by us to provide pension, retirement or similar benefits to members
10-K
2023 FY
EX-97.1
AUTL
Autolus Therapeutics plc
21 Mar 24
Annual report
4:55pm
with the Listing Standards; or (iii) recoupment of the applicable Recoverable Incentive Compensation would likely cause an otherwise tax-qualified retirement plan
8-K
EX-10.1
AUTL
Autolus Therapeutics plc
8 Feb 24
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
6:06am
, if such plan has total assets in excess of $5,000,000;
An employee benefit plan within the meaning of the Employee Retirement Income Security Act of 1974
S-3ASR
EX-4.7
sjlrco2
7 Feb 24
Automatic shelf registration
10:00pm
10-Q
wpr qi3h2ur
9 Nov 23
Quarterly report
4:18pm
6-K
EX-99.1
440xkqod drr5th2yf
2 Nov 23
Index to Condensed Consolidated Financial Statements
4:26pm
6-K
EX-99.1
xgkao u48efbi1ofwz
3 Aug 23
Index to Condensed Consolidated Financial Statements
4:32pm
6-K
EX-99.1
ecfva2jmav
4 May 23
Index to Condensed Consolidated Financial Statements
4:04pm
6-K
EX-1
2269j
1 Jul 22
Current report (foreign)
5:15pm
6-K
02319q 5ks7gwyqc
11 Jan 22
Autolus Therapeutics announces retirement of chief financial officer and succession plan
4:33pm
6-K
EX-99.1
t3f4lumxhx2
11 Jan 22
Autolus Therapeutics announces retirement of chief financial officer and succession plan
4:33pm
6-K
EX-99.1
o8i7rveu 1nsfk94
8 Nov 21
Securities Purchase Agreement
5:28pm
6-K
EX-99.1
k2mdaejx mf
3 Nov 21
Index to Condensed Consolidated Financial Statements
4:05pm
F-3
EX-4.4
bz0byy lo6hp
6 Aug 21
Shelf registration (foreign)
2:30pm
6-K
EX-99.1
hk3wg
5 Aug 21
Index to Condensed Consolidated Financial Statements
4:04pm
6-K
EX-1
tlgwv44g zdotr9
30 Jun 21
Annual Report and Accounts
6:05am
6-K
EX-99.1
u7wt1zybyp 6xp7hj0q
6 May 21
Index to Condensed Consolidated Financial Statements
4:05pm